Monoclonal antibody against human mac-1 and uses thereof

TW202626097APending Publication Date: 2026-07-01ASCENDO BIOTECHNOLOGY INC

0 Cites 0 Cited by

Patent Information

Application Number: TW115106117
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2022-05-25
Publication Date: 2026-07-01

Application Information

Patent Timeline

25 May 2022

Application

TW115106117

01 Jul 2026

Publication

TW202626097A

IPC: A61K39/395; A61P29/00; A61P35/00; C07K16/18

Inventors: 呂衍達; 張家鳴

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Monoclonal antibodies against human Mac-1 are provided. These antibodies can bind to different states of Mac-1 so as to alter the biofunctions of Mac-1. These antibodies can modulate Th1 / Th2 cytokine secretions by TLR-activated immune cells and can be used for the treatments of diseases related to acute and chronic inflammatory disorders, such as infectious diseases, and cancers.

Need to check novelty before this filing date? Find Prior Art